BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30626728)

  • 1. SPARC is required for the maintenance of glucose homeostasis and insulin secretion in mice.
    Atorrasagasti C; Onorato A; Gimeno ML; Andreone L; Garcia M; Malvicini M; Fiore E; Bayo J; Perone MJ; Mazzolini GD
    Clin Sci (Lond); 2019 Jan; 133(2):351-365. PubMed ID: 30626728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of the fibrosis and angiogenesis promoter SPARC/osteonectin in human adipose tissue by weight change, leptin, insulin, and glucose.
    Kos K; Wong S; Tan B; Gummesson A; Jernas M; Franck N; Kerrigan D; Nystrom FH; Carlsson LM; Randeva HS; Pinkney JH; Wilding JP
    Diabetes; 2009 Aug; 58(8):1780-8. PubMed ID: 19509023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SPARC is over-expressed in adipose tissues of diet-induced obese rats and causes insulin resistance in 3T3-L1 adipocytes.
    Shen Y; Zhao Y; Yuan L; Yi W; Zhao R; Yi Q; Yong T
    Acta Histochem; 2014 Jan; 116(1):158-66. PubMed ID: 23910024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SPARC promotes insulin secretion through down-regulation of RGS4 protein in pancreatic β cells.
    Hu L; He F; Huang M; Zhao Q; Cheng L; Said N; Zhou Z; Liu F; Dai YS
    Sci Rep; 2020 Oct; 10(1):17581. PubMed ID: 33067534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A role for SPARC in the moderation of human insulin secretion.
    Harries LW; McCulloch LJ; Holley JE; Rawling TJ; Welters HJ; Kos K
    PLoS One; 2013; 8(6):e68253. PubMed ID: 23840838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic AT1aR Deficiency Decreases Insulin Secretion in Obese C57BL/6 Mice.
    Shoemaker R; AlSiraj Y; Chen J; Cassis LA
    Am J Hypertens; 2019 May; 32(6):597-604. PubMed ID: 30903169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated plasma levels of SPARC in patients with newly diagnosed type 2 diabetes mellitus.
    Wu D; Li L; Yang M; Liu H; Yang G
    Eur J Endocrinol; 2011 Oct; 165(4):597-601. PubMed ID: 21778250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of SPARC (secreted protein acidic and rich in cysteine) in the pathogenesis of obesity, type 2 diabetes, and non-alcoholic fatty liver disease.
    Atorrasagasti C; Onorato AM; Mazzolini G
    J Physiol Biochem; 2023 Nov; 79(4):815-831. PubMed ID: 36018492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secreted protein acidic and rich in cysteine (SPARC) improves glucose tolerance
    Aoi W; Hirano N; Lassiter DG; Björnholm M; Chibalin AV; Sakuma K; Tanimura Y; Mizushima K; Takagi T; Naito Y; Zierath JR; Krook A
    FASEB J; 2019 Sep; 33(9):10551-10562. PubMed ID: 31225998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of SPARC enhances high-fat diet-induced obesity in mice.
    Nie J; Bradshaw AD; Delany AM; Sage EH
    Connect Tissue Res; 2011 Apr; 52(2):99-108. PubMed ID: 20615096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPARC: a key player in the pathologies associated with obesity and diabetes.
    Kos K; Wilding JP
    Nat Rev Endocrinol; 2010 Apr; 6(4):225-35. PubMed ID: 20195270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SPARC inhibits adipogenesis by its enhancement of beta-catenin signaling.
    Nie J; Sage EH
    J Biol Chem; 2009 Jan; 284(2):1279-90. PubMed ID: 18990699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PI3Kγ ablation does not promote diabetes in
    Breasson L; Sardi C; Becattini B; Zani F; Solinas G
    FASEB J; 2018 Jan; 32(1):319-329. PubMed ID: 28904022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The matricellular protein SPARC/osteonectin as a newly identified factor up-regulated in obesity.
    Tartare-Deckert S; Chavey C; Monthouel MN; Gautier N; Van Obberghen E
    J Biol Chem; 2001 Jun; 276(25):22231-7. PubMed ID: 11294850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of secreted protein acidic and rich in cysteine during adipose conversion and adipose tissue hyperplasia.
    Chavey C; Boucher J; Monthouël-Kartmann MN; Sage EH; Castan-Laurell I; Valet P; Tartare-Deckert S; Van Obberghen E
    Obesity (Silver Spring); 2006 Nov; 14(11):1890-7. PubMed ID: 17135603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagon-like peptide-2 receptor modulates islet adaptation to metabolic stress in the ob/ob mouse.
    Bahrami J; Longuet C; Baggio LL; Li K; Drucker DJ
    Gastroenterology; 2010 Sep; 139(3):857-68. PubMed ID: 20546737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-fat diet induces early-onset diabetes in heterozygous Pax6 mutant mice.
    Chen Y; Feng R; Wang H; Wei R; Yang J; Wang L; Wang H; Zhang L; Hong TP; Wen J
    Diabetes Metab Res Rev; 2014 Sep; 30(6):467-75. PubMed ID: 24925705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of photobiomodulation on glucose homeostasis and morphometric parameters in pancreatic islets of diabetic mice.
    Bonifacio M; Benfato ID; de Almeida Cruz M; de Sales DC; Pandolfo IL; Quintana HT; Carvalho CPF; de Oliveira CAM; Renno ACM
    Lasers Med Sci; 2022 Apr; 37(3):1799-1809. PubMed ID: 34604943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SPARC-null mice exhibit increased adiposity without significant differences in overall body weight.
    Bradshaw AD; Graves DC; Motamed K; Sage EH
    Proc Natl Acad Sci U S A; 2003 May; 100(10):6045-50. PubMed ID: 12721366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secreted protein acidic and rich in cysteine and bioenergetics: Extracellular matrix, adipocytes remodeling and skeletal muscle metabolism.
    Ghanemi A; Melouane A; Yoshioka M; St-Amand J
    Int J Biochem Cell Biol; 2019 Dec; 117():105627. PubMed ID: 31589923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.